Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2020 Nov;33(6):778-787.
doi: 10.1111/pcmr.12878. Epub 2020 Apr 12.

The enigma and challenges of vitiligo pathophysiology and treatment

Zalfa A Abdel-Malek  1 , Christian Jordan  1 , Tina Ho  1 , Parth Rajendrakumar Upadhyay  1   2 , Alan Fleischer  1 , Iltefat Hamzavi  3
Affiliations
Review

The enigma and challenges of vitiligo pathophysiology and treatment

Zalfa A Abdel-Malek et al. Pigment Cell Melanoma Res. 2020 Nov.

Abstract

Vitiligo is the most common acquired pigmentary disorder, which afflicts 0.5%-1% of the world population, and is characterized by depigmented skin patches resulting from melanocyte loss. Vitiligo has a complex etiology and varies in its manifestations, progression, and response to treatment. It presents as an autoimmune disease, evidenced by circulating melanocyte-specific antibodies, and association with other autoimmune diseases. However, autoimmunity may be secondary to the high oxidative stress in vitiligo skin and to intrinsic defects in melanocytes and their microenvironment, which contribute to aberrant stress response, neo-antigenicity, and susceptibility of melanocytes to immune attack and apoptosis. There is also a genetic predisposition to vitiligo, which sensitizes melanocytes to environmental agents, such as phenolic compounds. Currently, there are different treatment modalities for re-pigmenting vitiligo skin. However, when repigmentation is achieved, the major challenge is maintaining the pigmentation, which is lost in 40% of cases. In this review, we present an overview of the clinical aspects of vitiligo, its pathophysiology, the intrinsic defects in melanocytes and their microenvironment, and treatment strategies. Based on lessons from the biology of human melanocytes, we present our perspective of how repigmentation of vitiligo skin can be achieved and sustained.

Keywords: apoptosis; autoimmunity; depigmentation; fibroblasts; keratinocytes; melanocytes; oxidative stress; paracrine factors; vitiligo.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

References

REFERENCES

    1. Abdel-Malek, Z. A., Kadekaro, A. L., Kavanagh, R. J., Todorovic, A., Koikov, L. N., Mcnulty, J. C., … Knittel, J. J. (2006). Melanoma prevention strategy based on using tetrapeptide alpha-MSH analogs that protect human melanocytes from UV-induced DNA damage and cytotoxicity. The FASEB Journal, 20, 1561-1563.
    1. Abdel-Malek, Z., Swope, V. B., Pallas, J., Krug, K., & Nordlund, J. J. (1992). Mitogenic, melanogenic, and cAMP responses of cultured neonatal human melanocytes to commonly used mitogens. Journal of Cellular Physiology, 150, 416-425.
    1. Alikhan, A., Felsten, L. M., Daly, M., & Petronic-Rosic, V. (2011). Vitiligo: A comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. Journal of the American Academy of Dermatology, 65, 473-491.
    1. Alkhateeb, A., Fain, P. R., Thody, A., Bennett, D. C., & Spritz, R. A. (2003). Epidemiology of vitiligo and associated autoimmune diseases in Caucasian probands and their families. Pigment Cell Research, 16, 208-214.
    1. Bae, J. M., Chung, K. Y., Yun, S. J., Kim, H., Park, B. C., Kim, J. S., … Kim, M. (2019). Markedly reduced risk of internal malignancies in patients with vitiligo: A nationwide population-based cohort study. Journal of Clinical Oncology, 37, 903-911.

LinkOut - more resources